CASI Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-29.2M | $-29.4M | $223.0K | $1.3M |
| FY2025 | $-20.8M | $-20.8M | $16.0K | $3.0M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-29.2M | $-29.4M | $223.0K | $1.3M |
| FY2025 | $-20.8M | $-20.8M | $16.0K | $3.0M |